WST - Company ID 0000105770
WEST PHARMACEUTICAL SERVICES INC (WST) reported revenue of $3.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $3.07B | +6.3% |
| FY 2024 | $2.89B | -1.9% |
| FY 2023 | $2.95B | +2.2% |
| FY 2022 | $2.89B | +2.0% |
| FY 2021 | $2.83B | +31.9% |
| FY 2020 | $2.15B | +16.7% |
| FY 2019 | $1.84B | +7.1% |
| FY 2018 | $1.72B | +7.4% |
| FY 2017 |
WEST PHARMACEUTICAL SERVICES INC (WST) reported revenue of $3.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, WEST PHARMACEUTICAL SERVICES INC's revenue grew from $1.19B to $3.07B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.60B |
| +6.0% |
| FY 2016 | $1.51B | +7.8% |
| FY 2015 | $1.40B | -1.5% |
| FY 2014 | $1.42B | +3.9% |
| FY 2013 | $1.37B | +8.1% |
| FY 2012 | $1.27B | +6.2% |
| FY 2011 | $1.19B | - |